Skip to main content
Fig. 2 | Annals of General Psychiatry

Fig. 2

From: A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

Fig. 2

Trend chart of patients receiving different drug treatments. A HAMD-17 scores; B HAMA scores; C SHAPS scores; D MFI-20 scores; E MEQ scores; F PSQI score. HAMD-17: The 17-item Hamilton Depression Rating Scale; HAMA: Hamilton anxiety scale; SHAPS: Snaith-Hamilton Pleasure Scale; MFI-20: Multidimensional fatigue inventory-20; MEQ: Morningness–eveningness questionnaire; PSQI: Pittsburgh sleep quality index

Back to article page

Annals of General Psychiatry

ISSN: 1744-859X